Frequency and risk factors for incident and redetected Chlamydia trachomatis infection in sexually active, young, multi-ethnic women: a community based cohort study
- PMID: 25100744
- PMCID: PMC4215355
- DOI: 10.1136/sextrans-2014-051607
Frequency and risk factors for incident and redetected Chlamydia trachomatis infection in sexually active, young, multi-ethnic women: a community based cohort study
Abstract
Objective: To investigate the frequency and risk factors for incident and redetected Chlamydia trachomatis infection in sexually active, young, multi-ethnic women in the community.
Design: Cohort study.
Setting: 20 London universities and Further Education colleges.
Participants: 954 sexually experienced women, mean age 21.5 years (range 16-27), 26% from ethnic minorities, who were recruited to the Prevention of Pelvic Infection (POPI) chlamydia screening trial between 2004 and 2006, and returned repeat postal self-taken vaginal swabs 11-32 (median 16) months after recruitment.
Results: The estimated annual incidence of chlamydia infection among 907 women who tested negative at baseline was 3.4 per 100 person-years (95% CI 2.5 to 4.6 per 100 person-years), but 6.6 per 100 person-years (95% CI 4.5 to 9.3 per 100 person-years) in the 326 teenagers (<20 years). Predictors of incident chlamydia infection were age <20 years (relative risk (RR) 4.0, 95% CI 2.1 to 7.5), and (after adjusting for age) a new sexual partner during 12 months follow-up (RR 4.4, 95% CI 2.0 to 9.9), smoking (RR 2.2 95% CI 1.2 to 3.9), concurrent bacterial vaginosis (RR 2.0 95% CI 1.1 to 3.9) and high risk carcinogenic human papillomavirus (RR 2.2, 95% CI 1.1 to 4.3). Of 47 women positive for chlamydia at baseline, 12 (25.5%, 95% CI 13.9% to 40.3%) had redetected infection at a median of 16 months follow-up. Taking into account follow-up time (65 person-years), the annual redetection rate was 18.5 per 100 person-years (95% CI 9.9 to 30.0 per 100 person-years).
Conclusions: One in four women with chlamydia infection at baseline retested positive, supporting recent recommendations to routinely retest chlamydia positives.
Keywords: Chlamydia Infection; Chlamydia Trachomatis; Public Health; Sexual Health; Testing.
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Figures
Similar articles
-
Frequency and risk factors for prevalent, incident, and persistent genital carcinogenic human papillomavirus infection in sexually active women: community based cohort study.BMJ. 2012 Jun 22;344:e4168. doi: 10.1136/bmj.e4168. BMJ. 2012. PMID: 22730542 Free PMC article.
-
Risk Factors for Incident and Redetected Chlamydia trachomatis Infection in Women: Results of a Population-Based Cohort Study.Sex Transm Dis. 2016 Feb;43(2):113-9. doi: 10.1097/OLQ.0000000000000394. Sex Transm Dis. 2016. PMID: 26760181
-
Which sexually active young female students are most at risk of pelvic inflammatory disease? A prospective study.Sex Transm Infect. 2016 Feb;92(1):63-6. doi: 10.1136/sextrans-2015-052063. Epub 2015 Jun 16. Sex Transm Infect. 2016. PMID: 26082320 Free PMC article.
-
Randomised controlled trial of screening for Chlamydia trachomatis to prevent pelvic inflammatory disease: the POPI (prevention of pelvic infection) trial.BMJ. 2010 Apr 8;340:c1642. doi: 10.1136/bmj.c1642. BMJ. 2010. PMID: 20378636 Free PMC article. Clinical Trial.
-
Chlamydia trachomatis screening in young women.Curr Opin Obstet Gynecol. 2011 Oct;23(5):315-20. doi: 10.1097/GCO.0b013e32834ac776. Curr Opin Obstet Gynecol. 2011. PMID: 21897235 Review.
Cited by
-
Sexually Transmitted Infections Treatment Guidelines, 2021.MMWR Recomm Rep. 2021 Jul 23;70(4):1-187. doi: 10.15585/mmwr.rr7004a1. MMWR Recomm Rep. 2021. PMID: 34292926 Free PMC article.
-
Analysis of Factors Driving Incident and Ascending Infection and the Role of Serum Antibody in Chlamydia trachomatis Genital Tract Infection.J Infect Dis. 2016 Feb 15;213(4):523-31. doi: 10.1093/infdis/jiv438. Epub 2015 Sep 7. J Infect Dis. 2016. PMID: 26347571 Free PMC article.
-
A 30-Min Nucleic Acid Amplification Point-of-Care Test for Genital Chlamydia trachomatis Infection in Women: A Prospective, Multi-center Study of Diagnostic Accuracy.EBioMedicine. 2018 Feb;28:120-127. doi: 10.1016/j.ebiom.2017.12.029. Epub 2018 Jan 10. EBioMedicine. 2018. PMID: 29396306 Free PMC article.
-
Cervicovaginal microbiome and natural history of Chlamydia trachomatis in adolescents and young women.Cell. 2025 Feb 20;188(4):1051-1061.e12. doi: 10.1016/j.cell.2024.12.011. Epub 2025 Jan 15. Cell. 2025. PMID: 39818212 Free PMC article.
-
Sexual and testing behaviour associated with Chlamydia trachomatis infection: a cohort study in an STI clinic in Sweden.BMJ Open. 2016 Aug 26;6(8):e011312. doi: 10.1136/bmjopen-2016-011312. BMJ Open. 2016. PMID: 27566631 Free PMC article.
References
-
- Clinical Effectiveness Group, British Association for Sexual Health and HIV. Chlamydia trachomatis UK Testing Guidelines 2010.
-
- National Chlamydia Screening Programme Data Tables; Chlamydia Testing Data 2011/12 2013.
-
- Woodhall SC, Atkins JL, Soldan K. Repeat genital Chlamydia trachomatis testing rates in young adults in England, 2010. Sex Transm Infect 2013;89:51–6. - PubMed
-
- Lamontagne SD, Baster K, Emmet L. Incidence and reinfection rates of genital chlamydia infection among women aged 16–24 years attending general practice, family planning and genitourinary medicine clinics in England: a prospective cohort study by the Chlamydia Recall Study Advisory Group. Sex Transm Infect 2007;4:292–303. - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical